# US Non-Invasive Monitoring Device Market

> US Non-Invasive Monitoring Device Market Research Report: Size, Share, Trend Analysis By Types (Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices, Blood Glucose Monitoring Devices), By Modality (Table-Top Devices, Wearable Devices), By Applications (Cardiology, Neurology, Oncology) and By End Users (Hospitals & Clinics, Diagnostic Centers, Research & Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.43%
- **2024:** $ 5.38 Million
- **2025:** $ 5.83 Million
- **2035:** $ 13.1 Million
- **Key Players:** Medtronic (US), Philips (NL), Abbott (US), Siemens Healthineers (DE), GE Healthcare (US), Omron Healthcare (JP), Honeywell (US), Nihon Kohden (JP)

**Report ID:** MRFR/MED/18444-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-non-invasive-monitoring-device-market-19991

---

## Market Summary

## **US Non-Invasive Monitoring Device Market Overview**

As per MRFR analysis, the US Non-Invasive Monitoring Device Market Size was estimated at 119.05 (USD Million) in 2023. The US Non-Invasive Monitoring Device Market Industry is expected to grow from 125(USD Million) in 2024 to 586 (USD Million) by 2035. The US Non-Invasive Monitoring Device Market CAGR (growth rate) is expected to be around 15.08% during the forecast period (2025 - 2035).

### **Key US Non-Invasive Monitoring Device Market Trends Highlighted**

The US Non-Invasive Monitoring Device Market is experiencing significant growth due to several key market drivers. Among these, the increasing prevalence of chronic diseases such as diabetes and cardiovascular disorders is particularly noteworthy. As more individuals seek regular monitoring without the need for invasive procedures, the dependency on non-invasive solutions has risen, leading to greater adoption in healthcare settings.

Furthermore, advancements in technology have enhanced the accuracy and efficiency of these devices, making them more appealing to both healthcare providers and patients. Regulatory support in the form of expedited approval processes within the FDA has facilitated innovation and market entry for new products, further accelerating market growth.

There are numerous opportunities in the US Non-Invasive Monitoring Device Market that could be explored or captured by stakeholders. For example, the integration of telehealth services can amplify the use of remote monitoring devices, especially given the increasing demand for accessible healthcare solutions. The expanding aged population in the US presents a substantial opportunity as older adults often require ongoing health monitoring.

Developers focusing on user-friendly designs and leveraging cloud-based data management systems can significantly enhance patient engagement and satisfaction. Recent trends indicate a shift toward wearable technology, which allows patients to monitor their health metrics in real-time. The popularity of these devices has surged among health-conscious individuals and fitness enthusiasts, resulting in a burgeoning consumer market for non-invasive monitoring.

Additionally, data analytics and artificial intelligence are increasingly being integrated into non-invasive monitoring systems, providing more insightful health tracking and predictive capabilities. The convergence of these technological advancements shapes the future landscape of the US Non-Invasive Monitoring Device Market, highlighting its pivotal role in modern healthcare.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Non-Invasive Monitoring Device Market Drivers**

### **Increasing Prevalence of Chronic Diseases**

The US [Non-Invasive Monitoring Device Market](../../../reports/non-invasive-monitoring-device-market-1506) Industry is experiencing significant growth driven by the increasing prevalence of chronic diseases such as diabetes and cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), approximately 34.2 million Americans, or about 10.5% of the population, have diabetes.

This has increased the demand for monitoring devices that can help manage these conditions effectively and reduce complications. Well-known companies such as Abbott Laboratories and Medtronic are actively developing innovative non-invasive monitoring solutions aimed specifically at this population, thus driving market growth.

The focus on chronic disease management highlighted by the American Diabetes Association is encouraging healthcare providers to adopt these devices more widely, increasing their penetration within the US healthcare system.

### **Technological Advancements**

Rapid technological advancements in monitoring devices are a key driver of growth in the US Non-Invasive Monitoring Device Market Industry. Recent developments in sensor technology, data analytics, and wireless connectivity have resulted in sophisticated devices that provide real-time health monitoring without invasive procedures.

The National Institute of Health has reported a significant increase in research efforts on health technology innovations, with over $31 billion invested in Health Research and Development in the last year alone. Companies such as Philips Healthcare and Welch Allyn are leading these advancements, ensuring that healthcare providers can offer improved patient care, which consequently expands the market.

### **Rising Health Awareness and Preventive Healthcare**

Growing health awareness and a trend toward preventive healthcare are significantly propelling the US Non-Invasive Monitoring Device Market Industry. A survey conducted by the American Heart Association indicated that nearly 80% of Americans believe monitoring their health is essential to prevent diseases.

This has led to an increased adoption of health monitoring solutions, as consumers seek to manage their health proactively. Major healthcare organizations, like the Mayo Clinic, have started initiatives that emphasize non-invasive monitoring methods among patients, contributing to market growth.

As consumers become more health-conscious, the demand for devices that facilitate self-monitoring is projected to rise, thus expanding market opportunities.

## **US Non-Invasive Monitoring Device Market Segment Insights**

### **Non-Invasive Monitoring Device Market Type Insights**

The US Non-Invasive Monitoring Device Market showcases a diverse range of solutions tailored to enhance patient care and facilitate effective health monitoring. Within the Type segment, Cardiac Monitoring Devices hold a prominent position due to the increasing prevalence of cardiovascular diseases and the need for continuous heart rate and rhythm assessments, making it crucial in preventive healthcare.

Following closely are Brain Monitoring Devices, which are important for controlling neurological conditions, promoting early diagnostics, and improving patient management. The rising awareness of brain health significantly contributes to this device's adoption. Blood Pressure Monitoring Devices are critical in managing hypertension, as they are widely used in both clinical and home settings, helping patients and clinicians track blood pressure trends effectively.

Anesthesia Monitoring Devices play a vital role in surgical environments, ensuring patient safety throughout procedures by closely monitoring vital signs and anesthesia levels. These devices are integral in enhancing patient outcomes during surgery. Finally, Blood Glucose Monitoring Devices are becoming essential for diabetes management, with a growing number of patients turning to non-invasive options for ease of use and improved adherence to monitoring regimens.

The trends in this market reflect a strong focus on chronic disease management, technological advancements, and the rising demand for patient-centric healthcare solutions, indicating a robust evolution in the US Non-Invasive Monitoring Device Market and its associated segments.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Non-Invasive Monitoring Device Market Modality Insights**

The US Non-Invasive Monitoring Device Market is experiencing significant growth, particularly in the Modality segment which includes Table-Top Devices and Wearable Devices. These modalities are increasingly favored due to their ease of use and ability to provide real-time health data without the need for invasive procedures.

Table-Top Devices are often leveraged in clinical settings, providing healthcare professionals with essential monitoring capabilities for various health conditions, significantly enhancing patient care. Meanwhile, Wearable Devices are gaining traction among consumers for personal health monitoring, driven by the growing trend of health consciousness and the rise in chronic diseases.

As the demand for remote patient monitoring increases, wearable technology is becoming a preferred option for individuals seeking convenience and accessibility in health management. Moreover, advancements in technology are propelling innovation in these modalities, allowing for more accurate readings and improved functionalities.

The proliferation of mobile health applications is also supporting the integration of these devices, thereby streamlining data collection and enhancing user experience within the US Non-Invasive Monitoring Device Market.

### **Non-Invasive Monitoring Device Market Application Insights**

The US Non-Invasive Monitoring Device Market, particularly within the Application segment, is experiencing notable growth as it addresses critical health monitoring needs. This market encompasses vital areas such as Cardiology, Neurology, and Oncology, each playing a significant role in patient care and management.

Cardiology benefits from advancements in monitoring heart conditions, which is crucial given the high prevalence of cardiovascular diseases in the US. Neurology applications are vital for tracking neurological disorders, enhancing early diagnosis, and improving treatment processes, all of which address a growing patient population suffering from conditions such as stroke and epilepsy.

Oncology applications are increasingly important due to the rising incidence of cancer, with non-invasive monitoring devices providing essential updates on patient status and treatment response. The overall market demonstrates strong potential for growth, driven by advancements in technology, increasing healthcare spending, and a rising focus on preventive healthcare solutions, further highlighting the importance of this segment in improving patient outcomes and operational efficiencies in healthcare settings.

Additionally, the segmentation of the US Non-Invasive Monitoring Device Market reflects emerging opportunities as healthcare providers seek to enhance diagnostic accuracy and patient monitoring through innovative and user-friendly devices.

### **Non-Invasive Monitoring Device Market End User Insights**

The End User segment of the US Non-Invasive Monitoring Device Market is diverse and consists of key areas such as Hospitals and Clinics, Diagnostic Centers, and Research and Academic Institutes. Hospitals and Clinics play a crucial role as they are primary locations where non-invasive monitoring technologies are widely adopted, largely due to their ability to enhance patient care and streamline operational efficiency.

These institutions often require real-time patient data to support critical decision-making. Diagnostic Centers are vital in this segment as they leverage these devices for accurate assessments and early disease detection, thereby ensuring timely interventions for patients. Research and Academic Institutes contribute significantly, often driving innovation in non-invasive monitoring technologies through studies and trials, facilitating advancements that continuously improve patient outcomes.

The US market benefits from a growing emphasis on preventive care and personalized medicine, creating substantial opportunities for the expansion of this segment. Furthermore, stringent regulations and healthcare policies in the US promote the adoption of advanced monitoring solutions, ensuring that the demand within this segment remains robust.

Overall, this segment is positioned to leverage advancements in technology, catering to an evolving healthcare landscape focused on efficiency and improved patient experiences.

## **US Non-Invasive Monitoring Device Market Key Players and Competitive Insights**

The US Non-Invasive Monitoring Device Market is characterized by a diverse array of innovative technologies aimed at facilitating real-time patient monitoring without the need for invasive procedures. This sector is rapidly expanding, driven by advancements in technology, an increasing focus on patient-centered care, and a growing prevalence of chronic diseases that necessitate ongoing monitoring.

Companies within this market are tapping into opportunities fueled by the rising demand for wearable devices, telehealth services, and home healthcare solutions. With intense competition and a multitude of players, the market landscape is continually evolving as organizations strive to differentiate themselves through unique offerings and superior customer experiences.

As healthcare practices migrate toward non-invasive solutions, the focus on regulatory compliance and patient privacy remains critical, influencing how companies design and market their monitoring devices.

iRhythm Technologies has secured a noteworthy position within the US Non-Invasive Monitoring Device Market, primarily through its innovative approach to cardiac monitoring. The company specializes in providing advanced diagnostic tools that connect patients and healthcare providers via digital platforms. iRhythm's flagship product, a non-invasive cardiac rhythm monitor, has made significant strides in enhancing patient compliance and workflow efficiency for clinicians.

The company's strength lies in its proprietary algorithms and data analytics capabilities, which allow for accurate arrhythmia detection and enhanced patient care. Additionally, iRhythm's strategic partnerships with healthcare systems and commitment to enhancing patient outcomes bolster its competitive edge, ensuring a strong presence in both the clinical and ambulatory care sectors in the US.

Medtronic is a prominent player in the US Non-Invasive Monitoring Device Market, with a diverse portfolio of products focused on improving patient outcomes through innovative technology. Known for its commitment to advancing healthcare, Medtronic's key offerings include remote patient monitoring solutions and non-invasive diagnostic tools that cater to various medical fields.

The company's strengths comprise extensive research and development capabilities, a robust distribution network, and strategic collaborations that expand its reach in the US market. Medtronic has strengthened its position through various mergers and acquisitions, which have augmented its technology base and market presence. These efforts underscore the company’s determination to lead the market by providing comprehensive solutions that meet the evolving needs of practitioners and patients alike.

The integration of sophisticated algorithms and user-friendly interfaces in their products further enhances their appeal in the healthcare sector.

### **Key Companies in the US Non-Invasive Monitoring Device Market Include**

## **US Non-Invasive Monitoring Device Market Industry Developments**

The US Non-Invasive Monitoring Device Market has seen significant developments recently, particularly with the emergence of advanced technologies in wearable health devices. In October 2023, iRhythm Technologies announced improvements in its Zio service, enhancing patient monitoring capabilities with advanced algorithms, which contributes to the overall growth and efficiency of the market.

Medtronic continues to innovate with its remote monitoring solutions, responding effectively to the demand for telehealth services influenced by the COVID-19 pandemic. There have also been notable mergers and acquisitions, such as Abbott Laboratories' acquisition of Cardiologs in September 2023 to strengthen its cardiovascular monitoring portfolio.

This aligns with trends showing increased market valuation, as reported valuations increased significantly following these strategic advancements. In the past couple of years, companies like Philips and Siemens Healthineers have focused on developing cloud-based monitoring solutions, advocating for better data accessibility leading to improved patient outcomes.

The market is expected to grow further, bolstered by evolving consumer demand, technological advancements, and ongoing Research and Development initiatives across key players, including Masimo and GE Healthcare, who are developing innovative vital signs monitoring devices that improve patient care.

## **US Non-Invasive Monitoring Device Market Segmentation Insights**

### **Non-Invasive Monitoring Device Market Type Outlook**

### **Non-Invasive Monitoring Device Market Modality Outlook**

### **Non-Invasive Monitoring Device Market Application Outlook**

### **Non-Invasive Monitoring Device Market End User Outlook**

## Market Drivers

### Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is a primary driver for the non invasive-monitoring-device market. In the US, approximately 60% of adults have at least one chronic condition, which necessitates continuous monitoring. This trend is pushing healthcare providers to adopt non invasive solutions that allow for real-time health tracking without the discomfort associated with traditional methods. The demand for devices that can monitor vital signs, glucose levels, and other health metrics is expected to grow, as patients seek more convenient and less intrusive options. Consequently, the non invasive-monitoring-device market is likely to expand significantly, with projections indicating a potential market value exceeding $10 billion by 2027.

### Consumer Awareness and Health Literacy

Consumer awareness regarding health and wellness is on the rise, which is positively impacting the non invasive-monitoring-device market. As individuals become more informed about their health, they are increasingly seeking tools that enable them to monitor their conditions effectively. This heightened health literacy is driving demand for non invasive devices that provide accurate and accessible health data. Manufacturers are responding by creating devices that are not only effective but also user-friendly, appealing to a broader audience. The market is likely to benefit from this trend, with projections indicating a steady increase in sales as consumers prioritize their health and seek innovative solutions to monitor it.

### Technological Integration in Healthcare

The integration of advanced technologies such as artificial intelligence (AI), machine learning, and the Internet of Things (IoT) into healthcare is transforming the non invasive-monitoring-device market. These technologies enhance the functionality and accuracy of monitoring devices, enabling better data collection and analysis. For instance, AI algorithms can analyze patient data to predict health issues before they become critical, thereby improving patient outcomes. The market is witnessing a surge in the development of smart wearables that not only monitor health metrics but also provide actionable insights. This technological evolution is expected to drive the non invasive-monitoring-device market, with a projected growth rate of around 15% annually over the next five years.

### Increased Focus on Preventive Healthcare

There is a growing emphasis on preventive healthcare in the US, which is significantly influencing the non invasive-monitoring-device market. As healthcare costs continue to rise, both consumers and providers are recognizing the importance of early detection and management of health issues. Non invasive monitoring devices facilitate proactive health management by allowing individuals to track their health metrics regularly. This shift towards preventive care is likely to increase the adoption of these devices, as they empower users to take charge of their health. The market is expected to see a compound annual growth rate (CAGR) of approximately 12% as more consumers seek out non-invasive solutions to maintain their health.

### Aging Population and Demand for Home Healthcare

The aging population in the US is a significant driver for the non-invasive monitoring device market. As the baby boomer generation ages, there is an increasing demand for home healthcare solutions that allow elderly individuals to monitor their health from the comfort of their homes. Non invasive devices are particularly appealing to this demographic, as they offer ease of use and comfort. The market is responding to this demand by developing user-friendly devices that cater to the needs of older adults. It is estimated that by 2030, nearly 20% of the US population will be over 65, further propelling the growth of the non invasive-monitoring-device market as more seniors seek to manage their health independently.

## Future Outlook

The non invasive-monitoring-device market is projected to grow at an 8.43% CAGR from 2025 to 2035, driven by technological advancements and increasing health awareness.

**New opportunities:**

- Development of AI-driven predictive analytics tools for patient monitoring. Expansion into telehealth platforms for remote patient management. Partnerships with insurance companies for reimbursement models on non-invasive devices.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Type: Cardiac Monitors (Largest) vs. Blood Glucose Monitors (Fastest-Growing)

In the US non invasive-monitoring-device market, cardiac monitors hold the largest market share, significantly contributing to the overall sales volume and adoption rate. Following closely are blood pressure monitors, while blood glucose monitors are rapidly gaining traction, driven by increasing demand in diabetes management. Other segments like anaesthesia monitors and electrocardiogram monitors also play vital roles, but their market shares are relatively smaller compared to the leaders in this segment.

Growth trends within this segment highlight a shift towards more integrated and user-friendly devices. The rise in chronic diseases and the aging population fuel the demand for monitoring solutions, particularly for cardiac and blood glucose monitors. Additionally, advancements in technology are propelling innovation in these devices, making them more accessible and effective for patients, which is evidenced by the surge in the blood glucose monitors segment as the fastest-growing area.

Cardiac Monitors (Dominant) vs. Blood Glucose Monitors (Emerging)

Cardiac monitors remain dominant in the US non invasive-monitoring-device market, featuring advanced technologies that enable continuous heart rate tracking and early detection of cardiac events. These devices are critical for both hospital settings and home care, offering robust features that promote patient compliance and engagement. In contrast, blood glucose monitors are emerging as a vital option, particularly for the rising population of individuals with diabetes. These devices are becoming increasingly sophisticated, with features such as connectivity to mobile applications for real-time monitoring and data sharing. As both segments evolve, they showcase distinct characteristics where cardiac monitors emphasize reliability and precision, whereas blood glucose monitors focus on innovation and user-friendliness to enhance daily management of health.

### By Model: Wearable device (Largest) vs. Tabletop device (Fastest-Growing)

In the US non invasive-monitoring-device market, the wearable device segment dominates the landscape, capturing the largest share due to its convenience and versatility. This segment caters to a growing consumer preference for on-the-go health monitoring, further solidifying its market position. In contrast, the tabletop device segment, although smaller in share, is characterized by rapid growth and increasing adoption in clinical settings, fueled by advancements in technology and healthcare needs.

The growth trends in this market are driven by an increasing demand for [remote patient monitoring](https://www.marketresearchfuture.com/reports/remote-patient-monitoring-market-10905) and the rising prevalence of chronic diseases. Wearable devices benefit from innovations in sensor technology and user-friendly interfaces that appeal to health-conscious consumers. Meanwhile, tabletop devices are gaining traction for their accuracy and reliability in clinical applications, marking them as an important tool for healthcare providers in their quest to enhance patient outcomes.

Wearable device (Dominant) vs. Tabletop device (Emerging)

Wearable devices have established themselves as the dominant segment in the US non invasive-monitoring-device market, characterized by ongoing innovations that enhance user engagement and functionality. These devices are often equipped with advanced sensors that not only monitor vital signs but also promote user-interaction through mobile applications. Their ability to provide real-time data makes them invaluable for individual health management. On the other hand, tabletop devices represent an emerging segment, gaining popularity due to their precision and reliability. They are becoming increasingly favored in healthcare environments, offering professionals critical data for accurate diagnostics. Their advancements in technology are addressing the growing demand for non-invasive monitoring solutions, positioning them as a significant future player in this market.

### By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing)

The US non invasive-monitoring-device market showcases a diverse application portfolio, with oncology holding the largest share. This segment benefits from a growing emphasis on cancer management and early detection technologies, positioning it as a frontrunner in market distribution. Meanwhile, cardiology is rapidly gaining traction, addressing the increasing prevalence of cardiovascular diseases and the demand for remote patient monitoring solutions, making it a notable segment alongside oncology.

Recent growth trends indicate that the oncology segment’s dominance is fortified by continuous innovations in monitoring technologies and heightened awareness around cancer treatments. Conversely, the cardiology segment is experiencing rapid expansion due to advancements in wearable monitoring devices and a surge in telehealth services, driven by the COVID-19 pandemic. This convergence of healthcare technology and patient-centric care is propelling these segments forward.

Oncology (Dominant) vs. Neurology (Emerging)

Oncology has established itself as the dominant segment in the US non invasive-monitoring-device market due to its comprehensive range of applications in cancer detection, treatment monitoring, and follow-up care. Innovations such as blood-based biomarkers and portable imaging technologies are enhancing its appeal to providers and patients alike. Meanwhile, neurology is emerging as a promising segment, driven by the increasing focus on neurological disorders such as Alzheimer’s and Parkinson’s diseases. The rise of non invasive monitoring technologies in neurology aims to improve patient outcomes through enhanced diagnostics and ongoing monitoring. This growth is spurred by technological advancements that facilitate remote assessments and continuous health tracking, making neurology a segment to watch in the coming years.

### Non-Invasive Monitoring Device Market End User Insights

The End User segment of the US Non-Invasive Monitoring Device Market is diverse and consists of key areas such as Hospitals and Clinics, Diagnostic Centers, and Research and Academic Institutes. Hospitals and Clinics play a crucial role as they are primary locations where non-invasive monitoring technologies are widely adopted, largely due to their ability to enhance patient care and streamline operational efficiency.

These institutions often require real-time patient data to support critical decision-making. Diagnostic Centers are vital in this segment as they leverage these devices for accurate assessments and early disease detection, thereby ensuring timely interventions for patients. Research and Academic Institutes contribute significantly, often driving innovation in non-invasive monitoring technologies through studies and trials, facilitating advancements that continuously improve patient outcomes.

The US market benefits from a growing emphasis on preventive care and personalized medicine, creating substantial opportunities for the expansion of this segment. Furthermore, stringent regulations and healthcare policies in the US promote the adoption of advanced monitoring solutions, ensuring that the demand within this segment remains robust.

## Competitive Benchmarking

The non-invasive monitoring device market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for patient-centric healthcare solutions. Key players such as Medtronic (US), Philips (NL), and Abbott (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on innovation through the development of advanced monitoring technologies, while Philips (NL) emphasizes partnerships to expand its digital health offerings. Abbott (US) is leveraging its strong portfolio in continuous glucose monitoring to capture a larger share of the market, indicating a trend towards specialization in specific health monitoring areas.The market structure appears moderately fragmented, with several players vying for dominance. Companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. This strategic focus not only improves responsiveness to market demands but also strengthens competitive positioning. The collective influence of these key players shapes a landscape where innovation and operational excellence are paramount.
In October Medtronic (US) announced a strategic partnership with a leading telehealth provider to integrate its non invasive monitoring devices into remote patient monitoring platforms. This move is likely to enhance Medtronic's reach and facilitate better patient engagement, aligning with the growing trend of telehealth solutions. Such partnerships may prove crucial in expanding market access and improving patient outcomes.
In September Philips (NL) launched a new line of wearable health monitors designed to provide real-time health data analytics. This initiative underscores Philips' commitment to digital transformation and positions the company to capitalize on the increasing consumer demand for health monitoring solutions. The integration of AI in these devices could potentially enhance predictive analytics, thereby improving patient care.
In August Abbott (US) expanded its continuous glucose monitoring system to include features that allow for integration with mobile health applications. This strategic enhancement not only broadens Abbott's product appeal but also reflects a growing trend towards interoperability in health technology. By facilitating seamless data sharing, Abbott is likely to strengthen its competitive edge in the diabetes management segment.
As of November the competitive trends in the non invasive-monitoring-device market are increasingly defined by digitalization, sustainability, and AI integration. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, shifting from price-based competition to a focus on technological innovation, supply chain reliability, and enhanced patient experiences. This transition may redefine market dynamics, compelling companies to invest in cutting-edge technologies and sustainable practices to maintain their competitive edge.

## Recent News & Developments

The US Non-Invasive Monitoring Device Market has seen significant developments recently, particularly with the emergence of advanced technologies in wearable health devices. In October 2023, iRhythm Technologies announced improvements in its Zio service, enhancing patient monitoring capabilities with advanced algorithms, which contributes to the overall growth and efficiency of the market.

Medtronic continues to innovate with its remote monitoring solutions, responding effectively to the demand for [telehealth services](https://www.marketresearchfuture.com/reports/telehealth-service-market-43509) influenced by the COVID-19 pandemic. There have also been notable mergers and acquisitions, such as Abbott Laboratories' acquisition of Cardiologs in September 2023 to strengthen its cardiovascular monitoring portfolio.

This aligns with trends showing increased market valuation, as reported valuations increased significantly following these strategic advancements. In the past couple of years, companies like Philips and Siemens Healthineers have focused on developing cloud-based monitoring solutions, advocating for better data accessibility leading to improved patient outcomes.

The market is expected to grow further, bolstered by evolving consumer demand, technological advancements, and ongoing Research and Development initiatives across key players, including Masimo and GE Healthcare, who are developing innovative vital signs monitoring devices that improve patient care.

## Report Scope

| MARKET SIZE 2024 | 5.38(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 5.83(USD Million) |
| MARKET SIZE 2035 | 13.1(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.43% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Philips (NL), Abbott (US), Siemens Healthineers (DE), GE Healthcare (US), Omron Healthcare (JP), Honeywell (US), Nihon Kohden (JP) |
| Segments Covered | Type, Model, Application |
| Key Market Opportunities | Advancements in wearable technology enhance patient monitoring and drive growth in the non invasive-monitoring-device market. |
| Key Market Dynamics | Technological advancements drive growth in non invasive-monitoring-device market, enhancing patient care and regulatory compliance. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US non invasive-monitoring-device market in 2024?**
A: The market valuation was $5.38 Million in 2024.

**Q: What is the projected market valuation for the US non invasive-monitoring-device market in 2035?**
A: The projected valuation for 2035 is $13.1 Million.

**Q: What is the expected CAGR for the US non invasive-monitoring-device market during the forecast period 2025 - 2035?**
A: The expected CAGR is 8.43% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the US non invasive-monitoring-device market?**
A: Key players include Medtronic, Philips, Abbott, Siemens Healthineers, GE Healthcare, Omron Healthcare, Honeywell, and Nihon Kohden.

**Q: What are the main segments of the US non invasive-monitoring-device market?**
A: The main segments include Type, Model, and Application.

**Q: How did the cardiac monitors segment perform in 2024?**
A: The cardiac monitors segment was valued at $0.9 Million in 2024 and is expected to grow significantly.

**Q: What is the projected growth for wearable devices in the US non invasive-monitoring-device market?**
A: Wearable devices are projected to grow from $2.69 Million in 2024 to $6.5 Million by 2035.

**Q: What is the expected performance of the cardiology application segment?**
A: The cardiology application segment was valued at $2.15 Million in 2024 and is projected to reach $5.1 Million by 2035.

**Q: How does the blood pressure monitor segment compare to other segments?**
A: The blood pressure monitor segment was valued at $1.2 Million in 2024 and is expected to grow to $3.0 Million by 2035.

**Q: What trends are anticipated in the US non invasive-monitoring-device market by 2035?**
A: Trends suggest a robust growth trajectory, with increasing demand for advanced monitoring technologies and innovations.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-non-invasive-monitoring-device-market-19991*
